Epidemiology and risk factors for invasive candidiasis

Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · see citing works

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · see citing works

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724 · see citing works

Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010

Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A. K., Patel, J. B., Srinivasan, A., Kallen, A. J., Limbago, B. M., Fridkin, S. K., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,593 · see citing works

Attributable Mortality of Nosocomial Candidemia, Revisited

Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140 · see citing works

Untitled work

(2006) · PubMed · Cited by 906 · see citing works

Candida Colonization and Subsequent Infections in Critically III Surgical Patients

Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798 · see citing works

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of <i>Candida</i> Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718 · see citing works

Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · see citing works

Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003

Almirante, B., Rodríguez-Pardo, D., Park, B. J., Cuenca‐Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sánchez, F., Ayats, J., Giménez, M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.4.1829-1835.2005 · Cited by 567 · see citing works

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)

Leroy, O., Gangneux, J., Montravers, P., Mira, J. P., Gouin, F., Sollet, J.-P., Carlet, J. M., Reynes, J., Rosenheim, M., Regnier, B., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819efac0 · Cited by 536 · see citing works

Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers

Colombo, A. L., Nucci, M., Park, B. J., Nouér, S. A., Arthington, B. A., da Matta, D. A., Warnock, D. W., & Morgan, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00773-06 · Cited by 525 · see citing works

Changing epidemiology of systemic fungal infections

Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524 · see citing works

Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study

Tortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology &amp; Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509 · see citing works

Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000

Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478 · see citing works

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

Pfaller, M. A., Neofytos, D., Diekema, D. J., Azie, N. E., Meier‐Kriesche, H., Quan, S.-P., & Horn, D. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.10.003 · Cited by 391 · see citing works

Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*

Kett, D. H., Azoulay, E., Echeverria, P. M., & Vincent, J.-L. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206c1ca · Cited by 389 · see citing works

Epidemiology of candidemia in Latin America: a laboratory-based survey

Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374 · see citing works

Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011.

Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366 · see citing works

The changing face of epidemiology of invasive fungal disease in Europe

Lass‐Flörl, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01691.x · Cited by 365 · see citing works

Candidaemia in Europe: epidemiology and resistance

Tortorano, A. M., Kibbler, C. C., Pemán, J., Bernhardt, H., Klingspor, L., & Grillot, R. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.002 · Cited by 349 · see citing works

The changing epidemiology of healthcare-associated candidemia over three decades

Diekema, D., Arbefeville, S., Boyken, L., Kroeger, J., & Pfaller, M. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.02.001 · Cited by 309 · see citing works

Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.

Lockhart, S. R., Iqbal, N., Cleveland, A. A., Farley, M. M., Harrison, L. H., Bolden, C. B., Baughman, W., Stein, B., Hollick, R., Park, B. J., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01283-12 · Cited by 299 · see citing works

Epidemiology of opportunistic fungal infections in Latin America

Nucci, M., Queiroz‐Telles, F., Tobón, A. M., Restrepo, A., & Colombo, A. L. (2010) · Clinical Infectious Diseases · doi:10.1086/655683 · Cited by 280 · see citing works

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY antimicrobial surveillance program (2008–2009)

Pfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274 · see citing works

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007): Stable incidence but changing epidemiology of a still frequently lethal infection

Sipsas, N. V., Lewis, R. E., Tarrand, J., Hachem, R., Rolston, K. V., Raad, I. I., & Kontoyiannis, D. P. (2009) · Cancer · doi:10.1002/cncr.24507 · Cited by 269 · see citing works

<i>Candida</i> Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01079-10 · Cited by 238 · see citing works

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01398-10 · Cited by 228 · see citing works

Invasive Candidiasis

Pappas, P. G. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.07.004 · Cited by 226 · see citing works

Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome

Bougnoux, M.-E., Kac, G., Aegerter, P., d’Enfert, C., Fagon, J.-Y., & CandiRea Study Group (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0865-y · Cited by 224 · see citing works

National Surveillance of Fungemia in Denmark (2004 to 2009)

Arendrup, M. C., Bruun, B., Christensen, J. J., Fuursted, K., Johansen, H. K., Kjældgaard, P., Knudsen, J. D., Kristensen, L., Møller, J., Nielsen, L., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01811-10 · Cited by 223 · see citing works

Factors Associated with Candidemia Caused by Non‐albicans CandidaSpecies VersusCandida albicansin the Intensive Care Unit

Chow, J. K. L., Golan, Y., Ruthazer, R., Karchmer, A. W., Carmeli, Y., Lichtenberg, D. A., Chawla, V., Young, J., & Hadley, S. (2008) · Clinical Infectious Diseases · doi:10.1086/529435 · Cited by 222 · see citing works

Epidemiology of candidemia in intensive care units

Bouza, E., & Muñóz, P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70006-2 · Cited by 206 · see citing works

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

Arendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206 · see citing works

Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.

Dimopoulos, G., Ntziora, F., Rachiotis, G., Armaganidis, A., & Falagas, M. E. (2008) · Anesthesia &amp; Analgesia · doi:10.1213/ane.0b013e3181607262 · Cited by 189 · see citing works

Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)

Montagna, M. T., Caggiano, G., Lovero, G., Giglio, O. D., Coretti, C., Cuna, T., Iatta, R., Giglio, M., Dalfino, L., Bruno, F., et al. (2013) · Infection · doi:10.1007/s15010-013-0432-0 · Cited by 188 · see citing works

Management and outcome of bloodstream infections due to Candida species in England and Wales

Kibbler, C. C., Seaton, S., Barnes, R. A., Gransden, W. R., Holliman, R. E., Johnson, E. M., Perry, J. D., Sullivan, D. J., & Wilson, J. A. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00085-9 · Cited by 187 · see citing works

Active Surveillance of Candidemia, Australia

Chen, S., Slavin, M. A., Nguyen, Q. A., Marriott, D. J. E., Playford, E. G., Ellis, D., Sorrell, T. C., & Study, T. A. C. (2006) · Emerging infectious diseases · doi:10.3201/eid1210.060389 · Cited by 174 · see citing works

Candidemia in Norway (1991 to 2003): Results from a Nationwide Study

Sandven, P., Bevanger, L. S., Digranes, A., Haukland, H. H., Mannsåker, T., Gaustad, P., & the Norwegian Yeast Study Group (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00029-06 · Cited by 173 · see citing works

International Surveillance of Candida spp. and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2003)

Messer, S. A., Jones, R. N., & Fritsche, T. R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1782-1787.2006 · Cited by 172 · see citing works

Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and Neonates

Steinbach, W. J., Roilides, E., Berman, D., Hoffman, J. A., Groll, A. H., Bin-Hussain, I. Z., Palazzi, D. L., Castagnola, E., Halasa, N., Velegraki, A., et al. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182737427 · Cited by 171 · see citing works

Candida spp. colonization significance in critically ill medical patients: a prospective study

Charles, P., Dalle, F., Aube, H., Doise, J. M., Quenot, J., Aho, S., Chavanet, P., & Blettery, B. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2571-y · Cited by 169 · see citing works

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

Pemán, J., Cantón, R., Quindós, G., Eraso, E., Alcoba-Flórez, J., Guinea, J., Merino, P., Ruiz-Pérez-de-Pipaon, M. T., del Molino, L. P., Linares-Sicilia, M. J., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks019 · Cited by 159 · see citing works

Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp.

Playford, E. G., Marriott, D. J. E., Nguyen, Q. A., Chen, W., Ellis, D., Slavin, M. A., & Sorrell, T. C. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181760f42 · Cited by 156 · see citing works

Secular trends in candidemia-related hospitalization in the United States, 2000–2005

Zilberberg, M. D., Shorr, A. F., & Kollef, M. H. (2008) · Infection Control &amp; Hospital Epidemiology · doi:10.1086/591033 · Cited by 137 · see citing works

Candidemia in Finland, 1995–1999

Poikonen, E., Lyytikäinen, O., Anttila, V., & Ruutu, P. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030069 · Cited by 121 · see citing works

Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals

Bassetti, M., Trecarichi, E. M., Righi, E., Sanguinetti, M., Bisio, F., Posteraro, B., Soro, O., Cauda, R., Viscoli, C., & Tumbarello, M. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.01.005 · Cited by 120 · see citing works

Epidemiology, treatment and outcome of candidemia: a five‐year review at three Canadian hospitals: Epidemiologie, Behandlung und ausgang von Candidämien: Eine Fünfjahresübersicht an drei kanadischen Hospitälern

Macphail, G. L. P., Taylor, G. D., Buchanan‐Chell, M., Ross, C., Wilson, S., & Kureishi, A. (2002) · Mycoses · doi:10.1046/j.1439-0507.2002.00741.x · Cited by 119 · see citing works

A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade

Tortorano, A. M., Prigitano, A., Lazzarini, C., Passera, M., Deiana, M. L., Cavinato, S., De Luca, C., Grancini, A., Lo Cascio, G., Ossi, C., et al. (2013) · Infection · doi:10.1007/s15010-013-0455-6 · Cited by 110 · see citing works

Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005

Zepelin, M. B., Kunz, L., Rüchel, R., Reichard, U., Weig, M., & Groß, U. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm145 · Cited by 109 · see citing works

Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007

Poikonen, E., Lyytikäinen, O., Anttila, V.-J., Koivula, I., Lumio, J., Kotilainen, P., Syrjälä, H., & Ruutu, P. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-312 · Cited by 92 · see citing works

Invasive candidiasis in intensive care units in China: a multicentre prospective observational study

Guo, F., Yang, Y., Kang, Y., Zang, B., Cui, W., Qin, B., Qin, Y., Fang, Q., Qin, T., Jiang, D., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt083 · Cited by 91 · see citing works

Supplement: Trends in invasive Candida infections and their treatment: focus on echinocandins

Lewis, R. E. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902990817 · Cited by 89 · see citing works

Epidemiology and antifungal resistance in invasive candidiasis

Rodloff, A., Koch, D., & Schaumann, R. (2011) · European journal of medical research · doi:10.1186/2047-783x-16-4-187 · Cited by 89 · see citing works

Epidemiology and Antifungal Susceptibility of Bloodstream Fungal Isolates in Pediatric Patients: a Spanish Multicenter Prospective Survey

Pemán, J., Cantón, E., Linares-Sicilia, M. J., Roselló, E. M., Borrell, N., Ruiz-Pérez-de-Pipaon, M. T., Guinea, J., García, J., Porras, A., García-Tapia, A. M., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05474-11 · Cited by 75 · see citing works

Candidaemia in a European Paediatric University Hospital: a 10-year observational study

Tragiannidis, A., Fegeler, W., Rellensmann, G., Debus, V., Müller, V., Hoernig-Franz, I., Siam, K., Pana, Z. D., Jürgens, H., & Groll, A. H. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03720.x · Cited by 72 · see citing works

Evaluation of species distribution and risk factors of candidemia: A multicenter case-control study

Yapar, N., Pullukçu, H., Avkan-Oğuz, V., Kutlu, S. S., Ertuğrul, B., Saçar, S., Cetin, B., & Kaya, O. (2010) · Medical Mycology · doi:10.3109/13693786.2010.501344 · Cited by 70 · see citing works

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals

Nagao, M. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12083 · Cited by 68 · see citing works

Candidosis in the intensive care unit: a 20-year survey

Tortorano, A. M., Caspani, L., Rigoni, A. L., Biraghi, E., Sicignano, A., & Viviani, M. A. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.01.017 · Cited by 68 · see citing works

Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina.

Córdoba, S. B., Vivot, W., Bosco‐Borgeat, M. E., Taverna, C. G., Szusz, W., Murisengo, O. A., Isla, G., & Davel, G. (2011) · PubMed · doi:10.1590/s0325-75412011000300003 · Cited by 67 · see citing works

Candidaemia in Sweden: a nationwide prospective observational survey

Ericsson, J., Chryssanthou, E., Klingspor, L., Johansson, A. G., Ljungman, P. T., Svensson, E., & Sjölin, J. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12111 · Cited by 65 · see citing works

AMARCAND STUDY GROUP. EPIDEMIOLOGY, MANAGEMENT, AND RISK FACTORS FOR DEATH OF INVASIVE CANDIDA INFECTIONS IN CRITICAL CARE: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY IN FRANCE (2005-2006)

Leroy, O., Gangneux, J., & Montravers, P. (2009) · Cited by 57 · see citing works

The Epidemiology of Neonatal and Pediatric Candidemia in England and Wales, 2000–2009

Oeser, C., Lamagni, T. L., Heath, P. T., Sharland, M., & Ladhani, S. N. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318275612e · Cited by 44 · see citing works

No increase in primary nosocomial candidemia in 682 German intensive care units during 2006 to 2011

Meyer, E., Geffers, C., Gastmeier, P., & Schwab, F. (2013) · Eurosurveillance · doi:10.2807/ese.18.24.20505-en · Cited by 42 · see citing works

Candidemia among adults in Soweto, South Africa, 1990–2007

Kreusch, A., & Karstaedt, A. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.02.010 · Cited by 42 · see citing works

Retrospective Analysis of Epidemiology and Prognostic Factors for Candidemia at a Hospital in China, 2000^|^ndash;2009

Zhang, X., Yu, S.-J., Yu, J.-X., Gong, Y., Feng, W., & Sun, F. (2012) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.65.510 · Cited by 41 · see citing works

A one-year survey of candidemia in Belgium in 2002

Swinne, D., Watelle, M., Suetens, C., Mertens, K., Fonteyne, P.-A., & NOLARD, N. (2004) · Epidemiology and Infection · doi:10.1017/s095026880400295x · Cited by 39 · see citing works

Epidemiology and management of candidaemia - a retrospective, multicentre study in five hospitals in the UK

Chalmers, C., Gaur, S., Chew, J. L. L., Wright, T., Kumar, A., Mathur, S., Wan, W., Gould, I. M., Leanord, A., & Bal, A. M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02027.x · Cited by 36 · see citing works

The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study

Tan, T. Y., Tan, A. L., Tee, N. W. S., Ng, L. S. Y., & Chee, C. W. J. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01746.x · Cited by 28 · see citing works

National Surveillance of Fungemia in Denmark 2010-11

Arendrup, M. C., Dzajic, E., Johansen, H. K., Kjældgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L. B., Olesen, B. R. S., et al. (2012) · University of Southern Denmark Research Portal (University of Southern Denmark) · Cited by 14 · see citing works

Candida albicans—The Virulence Factors and Clinical Manifestations of Infection

Talapko, J., Juzbašić, M., Matijević, T., Pustijanac, E., Bekić, S., Kotris, I., & Škrlec, I. (2021) · Journal of Fungi · doi:10.3390/jof7020079 · Cited by 794 · see citing works

Candida Biofilms: Threats, Challenges, and Promising Strategies

Cavalheiro, M., & Teixeira, M. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00028 · Cited by 690 · see citing works

Mammalian lipoxygenases and their biological relevance

Kühn, H., Banthiya, S., & van Leyen, K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.002 · Cited by 629 · see citing works

Antifungal resistance: current trends and future strategies to combat

Wiederhold, N. P. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s124918 · Cited by 477 · see citing works

The Still Underestimated Problem of Fungal Diseases Worldwide

Almeida, F. B. D. R., Rodrigues, M. L., & Coelho, C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00214 · Cited by 452 · see citing works

Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis

Hargrove, T. Y., Friggeri, L., Wawrzak, Z., Qi, A., Hoekstra, W. J., Schotzinger, R. J., York, J. D., Guengerich, F. P., & Lepesheva, G. I. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.778308 · Cited by 444 · see citing works

The impact of the Fungus-Host-Microbiota interplay uponCandida albicansinfections: current knowledge and new perspectives

d’Enfert, C., Kaune, A.-K., Alaban, L. R., Chakraborty, S., Cole, N. L., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 351 · see citing works

Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis

Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.024 · Cited by 336 · see citing works

Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study

Lara, H. H., Romero-Urbina, D. G., Pierce, C., Lopez-Ribot, J. L., Arellano-Jiménez, M. J., & Jose-Yacaman, M. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0147-8 · Cited by 323 · see citing works

Investigating Colonization of the Healthy Adult Gastrointestinal Tract by Fungi

Auchtung, T. A., Fofanova, T. Y., Stewart, C. J., Nash, A. K., Wong, M. C., Gesell, J. R., Auchtung, J. M., Ajami, N. J., & Petrosino, J. F. (2018) · mSphere · doi:10.1128/msphere.00092-18 · Cited by 290 · see citing works

Fungal infections in animals: a patchwork of different situations

Seyedmousavi, S., Bosco, S. D. M. G., de Hoog, S., Ebel, F., Elad, D., Gomes, R. R., Jacobsen, I. D., Jensen, H. E., Martel, A., Mignon, B. R., et al. (2017) · Medical Mycology · doi:10.1093/mmy/myx104 · Cited by 263 · see citing works

Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia

Schmiedel, Y., & Zimmerli, S. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14281 · Cited by 226 · see citing works

Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition

Atriwal, T., Azeem, K., Husain, F. M., Hussain, A., Khan, M. N., Alajmi, M. F., & Abid, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.638609 · Cited by 210 · see citing works

Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species

Czajka, K. M., Venkataraman, K., Brabant-Kirwan, D., Santi, S. A., Verschoor, C. P., Appanna, V. D., Singh, R. I., Saunders, D., & Tharmalingam, S. (2023) · Cells · doi:10.3390/cells12222655 · Cited by 195 · see citing works

Candida Survival Strategies

Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 188 · see citing works

Diagnosis and Treatment of Invasive Candidiasis

Barantsevich, N. E., & Петровна, Б. Е. (2022) · Antibiotics · doi:10.3390/antibiotics11060718 · Cited by 193 · see citing works

Fungi of the human gut microbiota: Roles and significance

Pérez, J. C. (2021) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2021.151490 · Cited by 175 · see citing works

Candida albicans and Candida glabrata : global priority pathogens

Katsipoulaki, M., Stappers, M. H. T., Malavia, D., Brunke, S., Hube, B., & Gow, N. A. R. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00021-23 · Cited by 174 · see citing works

Nosocomial Fungal Infections

Anaissie, E. J., & Bodey, G. P. (1989) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30311-1 · Cited by 159 · see citing works

Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis

Jafri, H., & Ahmad, I. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.100911 · Cited by 153 · see citing works

Selenium nanoparticles from Lactobacillus paracasei HM1 capable of antagonizing animal pathogenic fungi as a new source from human breast milk

El‐Saadony, M. T., Saad, A. M., Taha, T. F., Najjar, A., Zabermawi, N. M., Nader, M. M., AbuQamar, S. F., El-Tarabily, K. A., & Salama, A. A. A. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.07.059 · Cited by 145 · see citing works

Nosocomial Fungal Infections

Suleyman, G., & Alangaden, G. J. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.07.008 · Cited by 138 · see citing works

Candida albicans and Oral Carcinogenesis. A Brief Review

Cosola, M. D., Cazzolla, A. P., Charitos, I. A., Ballini, A., Inchingolo, F., & Santacroce, L. (2021) · Journal of Fungi · doi:10.3390/jof7060476 · Cited by 147 · see citing works

Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options

Sardi, J. D. C. O., Silva, D. R., Mendes‐Giannini, M. J. S., & Rosalen, P. L. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.09.014 · Cited by 132 · see citing works

Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?

Sabino, R., Veríssimo, C., Pereira, Á. A., & Antunes, F. (2020) · Microorganisms · doi:10.3390/microorganisms8020181 · Cited by 133 · see citing works

Epidemiology of hospitalizations associated with invasive candidiasis, United States, 2002-20121

Strollo, S., Lionakis, M. S., Adjemian, J., Steiner, C. A., & Prevots, D. R. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2301.161198 · Cited by 129 · see citing works

Candida glabrata: A Lot More Than Meets the Eye

Kumar, K., Askari, F., Sahu, M. S., & Kaur, R. (2019) · Microorganisms · doi:10.3390/microorganisms7020039 · Cited by 128 · see citing works

Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds

Bondaryk, M., Staniszewska, M., Zielińska, P., & Urbańczyk-Lipkowska, Z. (2017) · Journal of Fungi · doi:10.3390/jof3030046 · Cited by 127 · see citing works

Candida albicans Chitin Increases Arginase-1 Activity in Human Macrophages, with an Impact on Macrophage Antimicrobial Functions

Wagener, J., MacCallum, D. M., Brown, G. D., & Gow, N. A. R. (2017) · mBio · doi:10.1128/mbio.01820-16 · Cited by 123 · see citing works

The Role of IL-17 in Protection against Mucosal Candida Infections

Mengesha, B., & Conti, H. R. (2017) · Journal of Fungi · doi:10.3390/jof3040052 · Cited by 123 · see citing works

Green biosynthesis of silver nanoparticles using novel endophytic Rothia endophytica: Characterization and anticandidal activity

Elbahnasawy, M. A., Shehabeldine, A. M., Khattab, A. M., Amin, B. H., & Hashem, A. H. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102401 · Cited by 118 · see citing works

Nosocomial Fungal Infections

Suleyman, G., & Alangaden, G. J. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.08.002 · Cited by 124 · see citing works

Formulation and in vitro evaluation of topical nanosponge-based gel containing butenafine for the treatment of fungal skin infection

Ahmed, M. M., Fatima, F., Anwer, M. K., Ibnouf, E. O., Kalam, M. A., Alshamsan, A., Aldawsari, M. F., Alalaiwe, A. S., & Ansari, M. J. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.04.010 · Cited by 116 · see citing works

Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents?

Bona, E., Cantamessa, S., Pavan, M., Novello, G., Massa, N., Rocchetti, A., Berta, G., & Gamalero, E. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13282 · Cited by 119 · see citing works

Nociceptors Boost the Resolution of Fungal Osteoinflammation via the TRP Channel-CGRP-Jdp2 Axis

Maruyama, K., Takayama, Y., Kondo, T., Ishibashi, K.-I., Sahoo, B. R., Kanemaru, H., Kumagai, Y., Martino, M. M., Tanaka, H., Ohno, N., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.002 · Cited by 115 · see citing works

Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China

Xiao, Z., Wang, Q., Zhu, F., & An, Y. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0534-2 · Cited by 109 · see citing works

Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic

Pilato, V. D., Codda, G., Ball, L., Giacobbe, D. R., Willison, E., Mikulska, M., Magnasco, L., Crea, F., Vena, A., Pelosi, P. P., et al. (2021) · Journal of Fungi · doi:10.3390/jof7020140 · Cited by 107 · see citing works

Investigation of the Antifungal Activity and Mode of Action of Thymus vulgaris, Citrus limonum, Pelargonium graveolens, Cinnamomum cassia, Ocimum basilicum, and Eugenia caryophyllus Essential Oils

Gucwa, K., Milewski, S., Dymerski, T., & Szweda, P. (2018) · Molecules · doi:10.3390/molecules23051116 · Cited by 106 · see citing works

The glyoxylate cycle and alternative carbon metabolism as metabolic adaptation strategies of Candida glabrata: perspectives from Candida albicans and Saccharomyces cerevisiae

Chew, S. Y., Chee, W. J. Y., & Than, L. T. L. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0546-5 · Cited by 105 · see citing works

Sugar Sensing and Signaling in Candida albicans and Candida glabrata

Ende, M. V., Wijnants, S., & Dijck, P. V. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00099 · Cited by 103 · see citing works

Activity of Novel Synthetic Peptides against Candida albicans

Lum, K. Y., Tay, S. T., Le, C. F., Lee, V. S., Sabri, N. H., Velayuthan, R. D., Hassan, H. H., & Sekaran, S. D. (2015) · Scientific Reports · doi:10.1038/srep09657 · Cited by 102 · see citing works

Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit

Pinhati, H. M. S., Casulari, L. A., Souza, A. C. R., Siqueira, R. A., Damasceno, C. M. G., & Colombo, A. L. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1767-9 · Cited by 102 · see citing works

Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of Candida spp. clinical isolates

de Alteriis, E., Maselli, V., Falanga, A., Galdiero, S., Lella, F. M. D., Gesuele, R., Guida, M., & Galdiero, E. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s164262 · Cited by 99 · see citing works

Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile

Sadeghi, G., Ebrahimi-Rad, M., Mousavi, S. F., Shams-Ghahfarokhi, M., & Razzaghi-Abyaneh, M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.12.008 · Cited by 96 · see citing works

Extracellular proteinases of <i>Candida</i> species pathogenic yeasts

Rapala‐Kozik, M., Bochenska, O., Zajac, D., Karkowska‐Kuleta, J., Gogol, M., Zawrotniak, M., & Kozik, A. (2018) · Molecular Oral Microbiology · doi:10.1111/omi.12206 · Cited by 94 · see citing works

Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries

Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93 · see citing works

Fungi as Part of the Microbiota and Interactions with Intestinal Bacteria

Kapitan, M., Niemiec, M. J., Steimle, A., Frick, J.-S., & Jacobsen, I. D. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_117 · Cited by 93 · see citing works

Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals

Goemaere, B., Becker, P., Wijngaerden, E. V., Maertens, J. A., Spriet, I., Hendrickx, M., & Lagrou, K. (2017) · Mycoses · doi:10.1111/myc.12714 · Cited by 91 · see citing works

Farnesol signalling in Candida albicans – more than just communication

Polke, M., Leonhardt, I., Kurzai, O., & Jacobsen, I. D. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1337711 · Cited by 87 · see citing works

Antifungal innate immunity: recognition and inflammatory networks

Becker, K. L., Ifrim, D. C., Quintin, J., Netea, M. G., & van de Veerdonk, F. L. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0467-z · Cited by 86 · see citing works

Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing

Spettel, K., Barousch, W., Makristathis, A., Zeller, I., Nehr, M., Selitsch, B., Lackner, M., Rath, P.-M., Steinmann, J., & Willinger, B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210397 · Cited by 86 · see citing works

UPLC-MS/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma

Xu, R.-A., Lin, Q., Qiu, X., Chen, J., Shao, Y., Hu, G., & Lin, G. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.12.036 · Cited by 85 · see citing works

Antibiofilm Activities of Biogenic Silver Nanoparticles Against Candida albicans

Ahamad, I., Bano, F., Anwer, R., Srivastava, P., Kumar, R., & Fatma, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.741493 · Cited by 86 · see citing works

Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India

Bhattacharjee, P. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.5 · Cited by 86 · see citing works

Antimicrobial and antibiofilm activities of nanoemulsions containing Eucalyptus globulus oil against Pseudomonas aeruginosa and Candida spp.

Quatrin, P. M., Verdi, C. M., de Souza, M. E., de Godoi, S. N., Klein, B., Gündel, A., Wagner, R. C., Vaucher, R. D. A., Ourique, A. F., & Santos, R. C. V. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.09.062 · Cited by 82 · see citing works

Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia

Seyoum, E., Bitew, A., & Mihret, A. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4883-5 · Cited by 87 · see citing works

Silver Nanoparticles Addition in Poly(Methyl Methacrylate) Dental Matrix: Topographic and Antimycotic Studies

Matteis, V. D., Cascione, M., Toma, C. C., Albanese, G., Giorgi, M. L. D., Corsalini, M., & Rinaldi, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194691 · Cited by 78 · see citing works

Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014

Chen, S. C., Sorrell, T. C., Chang, C. C., Paige, E. K., Bryant, P. A., & Slavin, M. A. (2014) · Internal Medicine Journal · doi:10.1111/imj.12597 · Cited by 78 · see citing works

Amphotericin B-conjugated biogenic silver nanoparticles as an innovative strategy for fungal infections

Ahmad, A., Wei, Y., Syed, F., Tahir, K., Taj, R., Khan, A. U., Hameed, M. U., & Yuan, Q. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.08.031 · Cited by 78 · see citing works

Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies

Emami, S., Ghobadi, E., Saednia, S., & Hashemi, S. M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.020 · Cited by 77 · see citing works

COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies

Ahmed, N., Mahmood, M. S., Ullah, M. A., Araf, Y., Rahaman, T. I., Moin, A. T., & Hosen, M. J. (2022) · Current Microbiology · doi:10.1007/s00284-022-02824-6 · Cited by 79 · see citing works

Function and subcellular localization of Gcn5, a histone acetyltransferase in Candida albicans.

Chang, P., Fan, X., & Chen, J. (2015) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.01.011 · Cited by 73 · see citing works

Bioinspired Zinc Oxide Nanoparticles Using Lycopersicon esculentum for Antimicrobial and Anticancer Applications

Vijayakumar, S., Vaseeharan, B., Sudhakaran, R., Jeyakandan, J., Ramasamy, P., Sonawane, A., Padhi, A., Velusamy, P., Anbu, P., & Faggio, C. (2019) · Journal of Cluster Science · doi:10.1007/s10876-019-01590-z · Cited by 72 · see citing works

Application of machine learning-assisted surface-enhanced Raman spectroscopy in medical laboratories: Principles, opportunities, and challenges

Tang, J., Yuan, Q., Zhang, L., Marshall, B. J., Tay, C. Y., & Wang, L. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118135 · Cited by 70 · see citing works

Candidemia in children: Epidemiology, prevention and management

Mantadakis, E., Pana, Z. D., & Zaoutis, T. E. (2018) · Mycoses · doi:10.1111/myc.12792 · Cited by 71 · see citing works

Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections

Dudhipala, N. R., & Youssef, A. A. A. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104953 · Cited by 69 · see citing works

Prevalence, virulence factors and antifungal susceptibility ofCandidaspp. isolated from bloodstream infections in a tertiary care hospital in Brazil

Canela, H. M. S., Cardoso, B., Vitali, L. H., Coêlho, H. C., Martínez, R., & Ferreira, M. E. D. S. (2017) · Mycoses · doi:10.1111/myc.12695 · Cited by 69 · see citing works

Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study

de Medeiros, M. A. P., de Melo, A. P. V., Bento, A. D. O., de Souza, L. B. F. C., Neto, F. D. A. B., Garcia, J. B.-L., Zuza-Alves, D. L., Francisco, E. C., Melo, A. S. D. A., & Chaves, G. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221033 · Cited by 68 · see citing works

Rapid proliferation due to better metabolic adaptation results in full virulence of a filament-deficient Candida albicans strain

Dunker, C., Polke, M., Schulze, B., Schubert, K., Rudolphi, S., Gressler, A. E., Pawlik, T., Prada, J. P., Niemiec, M. J., Slesiona, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24095-8 · Cited by 68 · see citing works

Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs

Romera, D., Aguilera-Correa, J. J., Gadea, I., Viñuela-Sandoval, L., García‐Rodríguez, J., & Esteban, J. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001036 · Cited by 68 · see citing works

Silibinin triggers yeast apoptosis related to mitochondrial Ca2+ influx in Candida albicans

Yun, D. G., & Lee, D. G. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.008 · Cited by 67 · see citing works

Silymarin exerts antifungal effects via membrane-targeted mode of action by increasing permeability and inducing oxidative stress

Yun, D. G., & Lee, D. G. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.01.009 · Cited by 67 · see citing works

Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience

Hirano, R., Sakamoto, Y., Kudo, K., & Ohnishi, M. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s80677 · Cited by 65 · see citing works

Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Candida Pathogens

Sharma, J., Rosiana, S., Razzaq, I., & Shapiro, R. S. (2019) · Journal of Fungi · doi:10.3390/jof5010017 · Cited by 64 · see citing works

Medically Important Fungi Respond to Azole Drugs: An Update

Zavřel, M., & White, T. C. (2015) · Future Microbiology · doi:10.2217/fmb.15.47 · Cited by 64 · see citing works

Remasking of Candida albicans β-Glucan in Response to Environmental pH Is Regulated by Quorum Sensing

Cottier, F., Sherrington, S. L., Cockerill, S., del Olmo, V., Kissane, S., Tournu, H., Orsini, L., Palmer, G. E., Pérez, J. C., & Hall, R. A. (2019) · mBio · doi:10.1128/mbio.02347-19 · Cited by 64 · see citing works

Effectiveness of Phytoactive Molecules on Transcriptional Expression, Biofilm Matrix, and Cell Wall Components of Candida glabrata and Its Clinical Isolates

Gupta, P., Gupta, S., Sharma, M., Kumar, N., Pruthi, V., & Poluri, K. M. (2018) · ACS Omega · doi:10.1021/acsomega.8b01856 · Cited by 64 · see citing works

Chilean crab (Aegla cholchol) as a new source of chitin and chitosan with antifungal properties against Candida spp

Bernabé, P., Becherán, L., Cabrera‐Barjas, G., Nešić, A., Claudio Alburquenque, O., Tapia, C. V., Taboada, E., Alderete, J. B., & Ríos-Escalante, P. D. L. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.01.126 · Cited by 63 · see citing works

Risk Factors of Candida parapsilosis Catheter-Related Bloodstream Infection

Yamin, D., Husin, A., & Harun, A. B. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.631865 · Cited by 65 · see citing works

Infrared Spectroscopy of Blood

Kochan, K., Bedolla, D. E., Pérez-Guaita, D., Adegoke, J. A., Veettil, T. C. P., Martin, M., Roy, S., Pebotuwa, S., Heraud, P., & Wood, B. R. (2020) · Applied Spectroscopy · doi:10.1177/0003702820985856 · Cited by 63 · see citing works

Characteristics and Management of Candidaemia Episodes in an Established Candida auris Outbreak

Bayona, J. V. M., Tormo, N., García, C. S., Rodríguez, P. H., de Medrano, V. A. L., Gómez, C. F., & Cardona, C. G. (2020) · Antibiotics · doi:10.3390/antibiotics9090558 · Cited by 62 · see citing works

Potential Synergistic Action of Bioactive Compounds from Plant Extracts against Skin Infecting Microorganisms

Sitarek, P., Merecz-Sadowska, A., Kowalczyk, T., Wieczfińska, J., Zajdel, R., & Śliwiński, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145105 · Cited by 71 · see citing works

The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis

Ifrim, D. C., Quintin, J., Courjol, F., Verschueren, I., van Krieken, J. H., Köentgen, F., Fradin, C., Gow, N. A. R., Joosten, L. A. B., van der Meer, J. W. M., et al. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0040 · Cited by 59 · see citing works

Propolis: A Potential Natural Product to Fight Candida Species Infections

Tobaldini-Valério, F. K., Mendonca, P., Rosseto, H. C., Bruschi, M. L., Henriques, M., Negri, M., Silva, S. M., & Svidzinski, T. I. E. (2016) · Future Microbiology · doi:10.2217/fmb-2015-0016 · Cited by 64 · see citing works

The Fungal Histone Acetyl Transferase Gcn5 Controls Virulence of the Human Pathogen Candida albicans through Multiple Pathways

Shivarathri, R., Tscherner, M., Zwolanek, F., Singh, N. K., Chauhan, N., & Kuchler, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45817-5 · Cited by 58 · see citing works

In silico Design of a Multivalent Vaccine Against Candida albicans

Tarang, S., Kesherwani, V., LaTendresse, B., Lindgren, L., Rocha-Sanchez, S. M., & Weston, M. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-57906-x · Cited by 58 · see citing works

Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis

Zhang, Z., Zhu, R., Luan, Z., & Ma, X. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036452 · Cited by 57 · see citing works

Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients

Bays, D. J., & Thompson, G. R. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.02.006 · Cited by 56 · see citing works

The role of pattern recognition receptors in the innate recognition ofCandida albicans

Zheng, N.-X., Wang, Y., Hu, D., Yan, L., & Jiang, Y. (2015) · Virulence · doi:10.1080/21505594.2015.1014270 · Cited by 55 · see citing works

Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey

Faria‐Ramos, I., Neves-Maia, J., Ricardo, E., Santos‐Antunes, J., Silva, A. P., Costa‐de‐Oliveira, S., Cantón, R., Rodrigues, A. G., & Pina‐Vaz, C. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2194-8 · Cited by 55 · see citing works

Attributable mortality of candidemia after introduction of echinocandins

Cornely, F. B., Cornely, O. A., Salmanton‐García, J., Koehler, F. C., Koehler, P. A., Seifert, H., Wingen-Heimann, S. M., & Mellinghoff, S. C. (2020) · Mycoses · doi:10.1111/myc.13177 · Cited by 54 · see citing works

Antibiofilm Activity on Candida albicans and Mechanism of Action on Biomembrane Models of the Antimicrobial Peptide Ctn[15–34]

de Aguiar, F. L. L., Santos, N. C., Cavalcante, C. S. D. P., Andreu, D., Rádis‐Baptista, G., & Gonçalves, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218339 · Cited by 54 · see citing works

Silver nanoparticle stabilized by hydrolyzed collagen and natural polymers: Synthesis, characterization and antibacterial-antifungal evaluation

Nogueira, S. S., de Araújo, A. R., Mafud, A. C., Guimarães, M. A., Alves, M. M. D. M., Plácido, A., Carvalho, F. A. D. A., Arcanjo, D. D. R., Mascarenhas, Y. P., Costa, F. G., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.05.214 · Cited by 54 · see citing works

An Atlas of Genetic Variation Linking Pathogen-Induced Cellular Traits to Human Disease

Wang, L., Pittman, K. J., Barker, J. R., Salinas, R., Stanaway, I. B., Williams, G. D., Carroll, R. J., Balmat, T., Ingham, A., Gopalakrishnan, A. M., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.07.007 · Cited by 54 · see citing works

Mode of action and anti-Candida activity of Artemisia annua mediated-synthesized silver nanoparticles

Khatoon, N., Sharma, Y., Sardar, M., & Manzoor, N. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.07.005 · Cited by 54 · see citing works

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor—Active Surveillance in Selected Sites, United States, 2014–2017

Zhang, A. Y., Shrum, S., Williams, S., Petnic, S., Nadle, J., Johnston, H., Barter, D., Vonbank, B., Bonner, L., Hollick, R., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1061 · Cited by 54 · see citing works

Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey

Dağı, H. T., Fındık, D., Senkeles, C., & Arslan, U. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0153-1 · Cited by 53 · see citing works

Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study

Hou, X., Xiao, M., Chen, S. C.-A., Kong, F., Wang, H., Chu, Y., Kang, M., Sun, Z., Hu, Z., Li, R., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00880 · Cited by 53 · see citing works

The changing spectrum of Saccharomycotina yeasts causing candidemia: phylogeny mirrors antifungal susceptibility patterns for azole drugs and amphothericin B

Stavrou, A. A., Lackner, M., Lass‐Flörl, C., & Boekhout, T. (2019) · FEMS Yeast Research · doi:10.1093/femsyr/foz037 · Cited by 51 · see citing works

The in vivo anti-Candida albicans activity of flavonoids

Nguyen, W., Grigori, L., Just, E., Santos, C., & Seleem, D. (2021) · Journal of Oral Biosciences · doi:10.1016/j.job.2021.03.004 · Cited by 54 · see citing works

Epidemiology of invasive fungal infection

Castón, J. J., Rivero, A., & Torre‐Cisneros, J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70009-8 · Cited by 105 · see citing works

Invasive candidiasis; a review article

Zarrin, M., & Mahmoudabadi, A. Z. (2009) · Jundishapur Journal of Microbiology · Cited by 24 · see citing works

Espectro y factores de riesgo de la infección fúngica invasora

Castón, J. J., Román, A. R., & Torre‐Cisneros, J. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13108710 · Cited by 6 · see citing works

Immunotherapy and Antifungal Drugs of Candidiasis: Achievements and Challenges

Maleki, L. A., Aghebati‐Maleki, A., Fotouhi, A., & Nami, S. (2021) · مجله دانشگاه علوم پزشکی اردبیل · doi:10.52547/jarums.21.3.249

Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China

Pu, S., Niu, S., Zhang, C., Xu, X., Qin, M., Huang, S., & Zhang, L. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2015.01.005 · Cited by 41 · see citing works